Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01CGV
|
|||
| Former ID |
DIB016697
|
|||
| Drug Name |
LY-2599506
|
|||
| Synonyms |
PSN-010
Click to Show/Hide
|
|||
| Indication | Diabetic complication [ICD-11: 5A2Y; ICD-9: 253.5, 588.1] | Phase 2 | [1] | |
| Company |
Prosidion Ltd
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H25N3O4S
|
|||
| Canonical SMILES |
C1CC1S(=O)(=O)C2=CC=C(C=C2)C(CC3CCOCC3)C(=O)NC4=NC=CN=C4
|
|||
| InChI |
1S/C21H25N3O4S/c25-21(24-20-14-22-9-10-23-20)19(13-15-7-11-28-12-8-15)16-1-3-17(4-2-16)29(26,27)18-5-6-18/h1-4,9-10,14-15,18-19H,5-8,11-13H2,(H,23,24,25)/t19-/m1/s1
|
|||
| InChIKey |
DQIITKNITDKAJZ-LJQANCHMSA-N
|
|||
| CAS Number |
CAS 745051-65-4
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01024244) A Study of LY2599506 in Patients With Type 2 Diabetes. U.S. National Institutes of Health. | |||
| REF 2 | This week in therapeutics Endocrine disease. SciBX 2(37); doi:10.1038/scibx.2009.1408. Sept. 24, 2009 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.